Download in electronic PDF format for $25



Search the Complete Journal Archives

Applying Quality of Design Concepts to Pharmacy Compounding

Author(s):  Timko Robert J

Issue:  Nov/Dec 2015 - Volume 19, Number 6
View All Articles in Issue

Abstract:  Compounding of medications is an important part of the practice of the pharmacy profession. Because compounded medications do not have U.S. Food and Drug Administration approval, a pharmacist has the responsibility to ensure that compounded medications are of suitable quality, safety, and efficacy. The Federal Government and numerous states have updated their laws and regulations regarding pharmacy compounding as a result of recent quality issues. Compounding pharmacists are expected to follow Current Good Compounding Practices in their compounding practices in much the same way pharmaceutical manufacturers are required to follow Current Good Manufacturing Procedures as detailed in the United States Code of Federal Regulations. Application of Quality by Design concepts to the preparation process for a compounded medication can help in understanding the potential pitfalls and the means to mitigate their impact. The goal is to build quality into the compounding process to ensure that the resultant compounded prescription meets the human or animal patients’ requirements.

Related Keywords: Robert J. Timko, RPh, PhD, quality assurance, drug safety, good compounding practices, U.S. federal pharmacy regulation, quality by design, pharmacy legislation, United States Pharmacopeial Convention, United States Pharmacopeia–National Formulary, U.S. Food and Drug Administration, quality standards, state boards of pharmacy, FDA guidance documents, outsourcing facilities, veterinary compounding, quality by design, process analytical technology, International Committee on Harmonization, Harmonized Tripartite Quality Guideline Documents, ICH, quality risk management, compounded product, control strategy

Related Categories: HISTORY, LEGAL, QUALITY CONTROL, UNITED STATES PHARMACOPEIA CONVENTIONS, INFORMATION RESOURCES

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Applying Quality of Design Concepts to Pharmacy Compounding Timko Robert J Nov/Dec 2015 453-463 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1 Allen Loyd V Jr Mar/Apr 2012 146-150 Buy
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Yoch Doug Mar/Apr 2017 95-102 Buy
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr Sep/Oct 2017 356 Buy
Prescription - Pharmacy and the United States Pharmaceopeia-National Formulary - From the Editor Allen Loyd V Jr May/Jun 2004 162 Buy
Quality Assurance and Quality Control, Part 2 Akers Michael J May/Jun 2015 215-221 Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G Jul/Aug 2015 303-305 Buy
Standing Together Fixing the Drug Quality and Security Act Miller David G Mar/Apr 2015 104-106 Buy
PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals Allen Loyd V Jr Sep/Oct 2016 356 Buy